0,886  0,004  CYP2D6 substrate
0,832  0,002  Antihypotensive
0,787  0,004  Vasodilator, peripheral
0,770  0,003  Alpha 2 adrenoreceptor antagonist
0,759  0,004  Psychostimulant
0,767  0,012  CYP3A4 substrate
0,719  0,004  Ulceration
0,718  0,004  Cardiodepressant
0,700  0,004  Sedative
0,696  0,004  Alpha adrenoreceptor antagonist
0,626  0,003  Alpha 2c adrenoreceptor antagonist
0,612  0,003  Alpha 2b adrenoreceptor antagonist
0,542  0,004  Alpha 2a adrenoreceptor antagonist
0,543  0,005  Male reproductive disfunction treatment
0,530  0,005  Cyclic AMP phosphodiesterase inhibitor
0,534  0,011  CYP2D6 inhibitor
0,516  0,021  Spasmolytic
0,487  0,005  Erectile dysfunction treatment
0,491  0,008  Anesthetic general
0,471  0,004  Acetylcholine M1 receptor antagonist
0,467  0,006  Antiadrenergic
0,482  0,035  Calcium channel L-type activator
0,461  0,018  Platelet antagonist
0,457  0,021  ICAM1 expression inhibitor
0,460  0,034  5 Hydroxytryptamine release stimulant
0,441  0,017  Vasodilator
0,420  0,003  Raynaud's phenomenon treatment
0,454  0,037  Teratogen
0,408  0,003  Acetylcholine M4 receptor antagonist
0,421  0,018  Calcium channel activator
0,408  0,008  Adrenaline antagonist
0,426  0,033  Antihypertensive
0,400  0,008  Acetylcholine antagonist
0,398  0,008  Cholinergic antagonist
0,396  0,007  Alpha 1 adrenoreceptor antagonist
0,382  0,004  ATPase inhibitor
0,388  0,056  Antiprotozoal (Plasmodium)
0,331  0,007  Acetylcholine muscarinic antagonist
0,344  0,032  Dependence treatment
0,358  0,048  Embryotoxic
0,317  0,008  Alpha 1a adrenoreceptor antagonist
0,313  0,005  Age-related macular degeneration treatment
0,402  0,113  Apoptosis agonist
0,289  0,005  VEGF expression inhibitor
0,341  0,057  Antipsychotic
0,344  0,067  Antineoplastic (colorectal cancer)
0,335  0,065  Antineoplastic (colon cancer)
0,350  0,092  Antiprotozoal
0,277  0,023  Cholinergic
0,319  0,066  NOS3 expression inhibitor
0,256  0,004  Acetylcholine muscarinic agonist
0,272  0,026  Antineoplastic (squamous cell carcinoma)
0,313  0,072  Anxiolytic
0,248  0,009  Acetylcholine agonist
0,243  0,005  Antineoplastic alkaloid
0,328  0,090  CYP2C9 substrate
0,291  0,057  Antiprotozoal (Leishmania)
0,306  0,073  Respiratory analeptic
0,237  0,005  Alpha 1 adrenoreceptor agonist
0,235  0,003  Glycine receptor antagonist
0,286  0,054  Antiglaucomic
0,247  0,018  Psychosexual dysfunction treatment
0,318  0,091  Antineoplastic (lung cancer)
0,240  0,013  Nav1.1 sodium channel blocker
0,235  0,011  Alpha 1b adrenoreceptor antagonist
0,229  0,005  Dopamine uptake inhibitor
0,316  0,096  Cognition disorders treatment
0,309  0,090  Transcription factor NF kappa B inhibitor
0,286  0,069  Antihypoxic
0,237  0,020  Antifungal enhancer
0,216  0,006  Acetylcholine M2 receptor antagonist
0,315  0,106  Immunosuppressant
0,269  0,062  Angiogenesis stimulant
0,271  0,063  Vascular (periferal) disease treatment
0,211  0,004  Acetylcholine M5 receptor antagonist
0,244  0,038  Macular degeneration treatment
0,295  0,091  Antithrombotic
0,233  0,031  Prostate disorders treatment
0,218  0,020  Antitussive
0,218  0,023  5 Hydroxytryptamine 2B antagonist
0,194  0,005  Antiprotozoal activity enhancer
0,214  0,027  Cocaine dependence treatment
0,326  0,141  Antidiabetic
0,326  0,141  Cyclophilin D inhibitor
0,314  0,131  Analgesic
0,229  0,046  Diabetic retinopathy treatment
0,277  0,101  Sodium/bile acid cotransporter inhibitor
0,226  0,050  P-glycoprotein inhibitor
0,269  0,094  Analeptic
0,217  0,047  Prostatic (benign) hyperplasia treatment
0,175  0,004  Narcotic antagonist
0,230  0,062  Platelet aggregation inhibitor
0,223  0,055  Antimigraine
0,228  0,061  Antialcoholic
0,299  0,132  15-Lipoxygenase inhibitor
0,169  0,003  Nicotinic alpha3beta2 receptor antagonist
0,329  0,164  Caspase 9 stimulant
0,178  0,013  5 Hydroxytryptamine uptake inhibitor
0,266  0,102  Interleukin 2 agonist
0,173  0,009  Acetylcholine M3 receptor agonist
0,185  0,023  MAP3K9 inhibitor
0,173  0,012  Alpha adrenoreceptor agonist
0,192  0,031  Neurotrophic factor
0,251  0,091  CYP2C19 substrate
0,263  0,106  Mood disorders treatment
0,225  0,069  Cytotoxic
0,269  0,116  Vasodilator, coronary
0,292  0,142  Antibacterial
0,158  0,009  Phosphodiesterase XI inhibitor
0,158  0,009  Phosphodiesterase 11A inhibitor
0,152  0,006  Alpha 2 adrenoreceptor agonist
0,276  0,130  Antineoplastic (breast cancer)
0,151  0,006  Dopamine transporter inhibitor
0,245  0,100  Cardioprotectant
0,250  0,109  Prostate cancer treatment
0,223  0,090  DNA synthesis inhibitor
0,241  0,110  Antidepressant
0,166  0,038  Nav1.6 sodium channel blocker
0,140  0,016  Alpha 1d adrenoreceptor antagonist
0,269  0,148  Antineoplastic (myeloid leukemia)
0,194  0,076  Abortion inducer
0,185  0,067  Sigma receptor agonist
0,223  0,105  5 Hydroxytryptamine 1E antagonist
0,189  0,072  Nitric oxide antagonist
0,169  0,052  Anesthetic
0,120  0,004  Vesicle monoamine transporter inhibitor
0,183  0,068  Lipocortins synthesis antagonist
0,200  0,087  Antiparasitic
0,126  0,015  Nicotinic alpha4beta2 receptor antagonist
0,254  0,144  Antineoplastic (endocrine cancer)
0,176  0,065  Irritable Bowel syndrome treatment
0,232  0,123  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,254  0,147  Antiasthmatic
0,116  0,015  Acetylcholine M3 receptor antagonist
0,219  0,118  Ca2+/calmodulin-dependent kinase IV inhibitor
0,179  0,078  Antiviral (Hepatitis)
0,122  0,022  Alpha 2d adrenoreceptor antagonist
0,123  0,023  Opioid kappa receptor antagonist
0,116  0,017  Female sexual dysfunction treatment
0,222  0,124  Antiischemic
0,211  0,117  Tyrosine 3 hydroxylase inhibitor
0,196  0,104  Cytostatic
0,183  0,092  Pneumotoxic
0,241  0,150  Stroke treatment
0,097  0,008  Acetylcholine M2 receptor agonist
0,220  0,131  Antifungal
0,198  0,109  Antineoplastic (liver cancer)
0,111  0,023  Phosphodiesterase V inhibitor
0,154  0,066  Antineoplastic (carcinoma)
0,104  0,018  Adrenaline uptake inhibitor
0,140  0,055  DNA polymerase I inhibitor
0,106  0,022  Calcium channel L-type blocker
0,092  0,010  Opioid kappa receptor agonist
0,224  0,143  CYP3A4 inhibitor
0,117  0,035  Tourette's syndrome treatment
0,169  0,089  Platelet adhesion inhibitor
0,117  0,037  Opioid antagonist
0,162  0,082  Muscle relaxant
0,181  0,103  Antiulcerative
0,158  0,082  UGT2B7 substrate
0,215  0,139  Hepatic disorders treatment
0,097  0,023  Glycine receptor agonist
0,190  0,118  Acute neurologic disorders treatment
0,133  0,063  Carcinogenic, group 3
0,125  0,055  Microtubule formation inhibitor
0,097  0,028  Phosphodiesterase 5A inhibitor
0,152  0,083  Uterine stimulant
0,164  0,096  Hepatoprotectant
0,102  0,038  Acetylcholine nicotinic antagonist
0,139  0,077  Antifungal (Cryptococcus)
0,118  0,057  Topoisomerase I inhibitor
0,176  0,117  Antineoplastic (lymphoma)
0,188  0,131  Cardiotonic
0,227  0,170  Toll-Like receptor 7 agonist
0,086  0,031  MAP kinase kinase 7 inhibitor
0,111  0,057  UGT2B1 substrate
0,239  0,184  CYP2C19 inhibitor
0,181  0,127  Antidiabetic symptomatic
0,075  0,021  CC chemokine 2 receptor antagonist
0,147  0,094  Antiviral (Hepatitis C)
0,075  0,025  Hypercalcemia treatment
0,062  0,012  Factor XIa inhibitor
0,156  0,107  UDP-glucuronosyltransferase substrate
0,153  0,104  Sleep disorders treatment
0,185  0,136  Antineoplastic (ovarian cancer)
0,151  0,103  Phospholipase C inhibitor
0,120  0,074  Nav1.3 sodium channel blocker
0,222  0,177  Toll-Like receptor agonist
0,230  0,186  Antipruritic, allergic
0,054  0,013  Farnesoid X receptor agonist
0,135  0,095  UGT2B9 substrate
0,133  0,093  NOS3 expression enhancer
0,133  0,095  Eye irritation, high
0,119  0,083  Phosphodiesterase inhibitor
0,104  0,069  5 Hydroxytryptamine 2 antagonist
0,065  0,034  Prolactin release inhibitor
0,074  0,043  Opioid mu receptor antagonist
0,050  0,021  Phosphodiesterase 6C inhibitor
0,088  0,059  ATPase (Vacuolar H+) inhibitor
0,196  0,168  Antileukemic
0,072  0,044  Neuronal nicotinic receptor antagonist
0,073  0,047  Prokinetic
0,089  0,065  SULT1E1 substrate
0,038  0,016  Acetylcholine M4 receptor agonist
0,112  0,091  Contraceptive
0,123  0,102  Skeletal muscle relaxant
0,108  0,087  Constipation treatment
0,122  0,103  Chemopreventive
0,047  0,027  Acetylcholine M1 receptor agonist
0,127  0,108  Adenylate cyclase stimulant
0,113  0,095  Calcium channel blocker
0,058  0,040  Lipocortins synthesis agonist
0,035  0,017  Prostaglandin D2 agonist
0,034  0,017  Dipeptidyl peptidase I inhibitor
0,044  0,027  Guanylate cyclase inhibitor
0,073  0,056  Analgesic, opioid
0,053  0,036  Opioid agonist
0,155  0,139  Antineoplastic (cervical cancer)
0,058  0,044  Androgen agonist
0,187  0,173  CYP1A2 substrate
0,088  0,076  Antiemetic
0,023  0,011  Vesicular acetylcholine transporter inhibitor
0,019  0,009  Prostacyclin agonist
0,059  0,051  Dopamine D1 antagonist
0,065  0,058  Protein kinase C beta inhibitor
0,086  0,079  Bronchodilator
0,020  0,014  Somatostatin 3 antagonist
0,124  0,119  Carcinogenic
0,059  0,055  5 Hydroxytryptamine agonist
0,083  0,079  Butyrylcholinesterase inhibitor
0,125  0,122  Interferon gamma antagonist
0,037  0,035  Dopamine D5 antagonist
0,072  0,070  5 Hydroxytryptamine 2C antagonist

